Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Medical student stars in local movie
2015-10-15


Sung-Hoon as the on-screen character Operator 2

Sung-Hoon Kim’s dream of starring in a movie became a reality with the release of Reconnect on 16 October 2015 in Nu Metro cinemas across the country.

The second-year medical student at the University of the Free State transitioned into a professional actor in December 2013, when he made the leap from his high school drama stage to shooting for the big screen.

“I did plays in high school where I had roles like Simba in The Lion King,” said the first-time movie star. 

The film is a purely South African creation. It is set in Potchefstroom and Klerksdorp, Sung-Hoon’s former and current hometowns. Sung-Hoon plays two major roles: XJ-1- a robot, and the on-screen role of artificial intelligence Operator 2 at SKY CORP - an international intelligence company that protects top secret information from around the world.

Reconnect was directed by the late Marius Swanepoel, who Sung-Hoon described as “a great blessing to all those privileged enough to have known him.” The movie explores the relationship between human beings and artificial intelligence.

Eric Scott discovers XJ-1 at an abandoned warehouse, and transfers him to SKY CORP where he becomes destructive. Eric and his friend, Jason, are then faced with the challenge of containing the situation, and saving the company which XJ-1 has infected with a dangerous virus. As the science-fiction action unfolds, viewers catch a glimpse into the life of XJ-1.

Shooting the movie was an exciting experience for Sung-Hoon. “It was quite fun because I like imitating voices,” he said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept